We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+1,105.06%
AUM
$25.2B
AUM Growth
+$145M
(+0.58%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
11.42%
Holding
1,496
New
423
Increased
299
Reduced
316
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$278M |
| 2 |
Analog Devices
ADI
|
+$181M |
| 3 |
Target
TGT
|
+$172M |
| 4 |
Visa
V
|
+$150M |
| 5 |
Broadcom
AVGO
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$454M |
| 2 |
Micron Technology
MU
|
+$168M |
| 3 |
Suncor Energy
SU
|
+$146M |
| 4 |
Cheniere Energy
LNG
|
+$129M |
| 5 |
Amazon
AMZN
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 16.94% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Industrials | 7.2% |
| 5 | Energy | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
776
DELISTED
Ventyx Biosciences
VTYX
| $3.07M | 0.01% |
+226,300
| New | +$3.02M |
|
777
AST SpaceMobile
ASTS
$20.4B
| $3.07M | 0.01% |
307,458
-167,712
| -35% | -$1.23M |
|
778
Mid-America Apartment Communities
MAA
$15.7B
| $3.06M | 0.01% |
14,600
+1,100
| +8% | +$230K |
|
779
Lifecore Biomedical
LFCR
$167M
| $3.03M | 0.01% |
261,556
+84,537
| +48% | +$941K |
|
780
Carter's
CRI
$1.47B
| $3.03M | 0.01% |
32,900
-58,601
| -64% | -$5.5M |
|
|
FSTX
781
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $3.02M | 0.01% |
850,000
-131,249
| -13% | -$485K |
|
782
Carvana
CVNA
$76.4B
| $3M | 0.01% |
+125,910
| New | +$3.67M |
|
|
CELL
783
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.97M | 0.01% |
+417,559
| New | +$3.45M |
|
784
Kemper
KMPR
$1.72B
| $2.96M | 0.01% |
52,400
+31,800
| +154% | +$1.76M |
|
785
Aecom
ACM
$9.63B
| $2.95M | 0.01% |
38,400
-115,200
| -75% | -$8.46M |
|
786
nLIGHT
LASR
$4.24B
| $2.94M | 0.01% |
+169,600
| New | +$3.19M |
|
787
XPO
XPO
$23.4B
| $2.93M | 0.01% |
67,776
-777,359
| -92% | -$32.5M |
|
788
Commercial Metals
CMC
$8.37B
| $2.92M | 0.01% |
70,200
-164,900
| -70% | -$6.19M |
|
|
MSP
789
DELISTED
Datto Holding Corp.
MSP
| $2.89M | 0.01% |
+108,200
| New | +$2.68M |
|
|
EPZM
790
DELISTED
Epizyme, Inc
EPZM
| $2.88M | 0.01% |
+2,500,000
| New | +$4.08M |
|
791
X4 Pharmaceuticals
XFOR
$391M
| $2.86M | 0.01% |
54,440
| – | – |
|
|
HSKA
792
DELISTED
Heska Corp
HSKA
| $2.83M | 0.01% |
20,473
-30,804
| -60% | -$4.36M |
|
793
PUT
Sonos
SONO
$1.88B
| $2.83M | 0.01% |
+100,300
| New | +$2.66M |
|
794
McDonald's
MCD
$195B
| $2.83M | 0.01% |
11,435
-109,722
| -91% | -$27.3M |
|
795
Under Armour Class C
UA
$2.82B
| $2.81M | 0.01% |
180,500
-248,300
| -58% | -$3.89M |
|
796
Middleby
MIDD
$6.12B
| $2.79M | 0.01% |
+17,000
| New | +$3.09M |
|
|
FUSN
797
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.72M | 0.01% |
350,000
-698,956
| -67% | -$5.07M |
|
798
MSCI
MSCI
$41.6B
| $2.71M | 0.01% |
5,388
+3,788
| +237% | +$1.96M |
|
|
FTCH
799
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2.67M | 0.01% |
176,903
-8,397
| -5% | -$163K |
|
800
Masco
MAS
$15.2B
| $2.66M | 0.01% |
52,200
-545,636
| -91% | -$32.4M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Point72 Asset Management held 1,496 positions worth $25.2B, up 0.58% from $25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management deployed $1.25B of net new capital in Q1 2022, opening 423 new positions and adding to 299 existing holdings. Its largest new stake was Target: 794,997 shares worth $169M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $168M trimmed.
- Point72 Asset Management's largest Q1 2022 buy was Target: 794,997 shares worth $169M.
- Point72 Asset Management added most to Merck in Q1 2022, an estimated $278M increase.
- Point72 Asset Management's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $168M.
- Point72 Asset Management fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $454M.
- Point72 Asset Management's ten largest holdings make up 11% of its $25.2B portfolio in Q1 2022.
- Point72 Asset Management opened 423 new positions and closed 358 in Q1 2022.
- Point72 Asset Management's portfolio value rose 0.58% quarter-over-quarter to $25.2B.
Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.